<SEC-DOCUMENT>0001847903-25-000069.txt : 20250514
<SEC-HEADER>0001847903-25-000069.hdr.sgml : 20250514
<ACCEPTANCE-DATETIME>20250514070834
ACCESSION NUMBER:		0001847903-25-000069
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20250514
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250514
DATE AS OF CHANGE:		20250514

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Centessa Pharmaceuticals plc
		CENTRAL INDEX KEY:			0001847903
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			X0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40445
		FILM NUMBER:		25942607

	BUSINESS ADDRESS:	
		STREET 1:		3RD FLOOR
		STREET 2:		1 ASHLEY ROAD
		CITY:			ALTRINCHAM, CHESHIRE
		STATE:			X0
		ZIP:			WA14 2DT
		BUSINESS PHONE:		44 7391 789784

	MAIL ADDRESS:	
		STREET 1:		3RD FLOOR
		STREET 2:		1 ASHLEY ROAD
		CITY:			ALTRINCHAM, CHESHIRE
		STATE:			X0
		ZIP:			WA14 2DT

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Centessa Pharmaceuticals Ltd
		DATE OF NAME CHANGE:	20210224
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>cnta-20250514.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:933a1ab4-4bc8-4269-b782-1ba9a40db680,g:18cc038a-1bac-4078-bb61-becd6ee8e29c,d:4bba4f261f6b44bcb1314598cee902ad-->
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:cnta="http://www.cnta.com/20250514" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns="http://www.w3.org/1999/xhtml" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>cnta-20250514</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-28">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-29">0001847903</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="cnta-20250514.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001847903</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-05-14</xbrli:startDate><xbrli:endDate>2025-05-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001847903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-05-14</xbrli:startDate><xbrli:endDate>2025-05-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001847903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cnta:AmericanDepositarySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-05-14</xbrli:startDate><xbrli:endDate>2025-05-14</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i4bba4f261f6b44bcb1314598cee902ad_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:20.029%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:100%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric></span></div></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date of Report (date of earliest event reported): <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">May 14, 2025</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:20.029%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">CENTESSA PHARMACEUTICALS PLC</ix:nonNumeric></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:20.029%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of Registrant, as specified in its charter)</span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:31.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.846%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:edgarprovcountryen" id="f-4">England and Wales</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-40445</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-6">98-1612294</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Commission File Number)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification Number)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mailing address:</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-7">3rd Floor</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine2" id="f-8">1 Ashley Road</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine3" id="f-9">Altrincham</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-10">Cheshire</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-11">WA14 2DT</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCountry" format="ixt-sec:countrynameen" id="f-12">United Kingdom</ix:nonNumeric></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Address of principal executive offices) (Zip code)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Registrant's telephone number, including area code: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:CountryRegion" id="f-13">+1</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-14">(617)</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-15">468-5770</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Former name or address, if changed since last report:&#160;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):&#160;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="f-16">&#9744;</ix:nonNumeric> Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)&#160;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="f-17">&#9744;</ix:nonNumeric> Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)&#160;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="f-18">&#9744;</ix:nonNumeric> Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))&#160;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="f-19">&#9744;</ix:nonNumeric> Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))&#160;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:35.263%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.419%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.987%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.419%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:35.412%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonNumeric contextRef="c-2" name="dei:Security12bTitle" id="f-20">Ordinary shares, nominal value &#163;0.002 per share</ix:nonNumeric> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-2" name="dei:TradingSymbol" id="f-21">CNTA</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonNumeric contextRef="c-2" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-22">Nasdaq Stock Market, LLC</ix:nonNumeric>*</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonNumeric contextRef="c-3" name="dei:Security12bTitle" id="f-23">American Depositary Shares, each representing one ordinary share, nominal value &#163;0.002 per share</ix:nonNumeric> </span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-3" name="dei:TradingSymbol" id="f-24">CNTA</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonNumeric contextRef="c-3" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-25">Nasdaq Stock Market, LLC</ix:nonNumeric></span></div></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*Not for trading, but only in connection with the listing of the American Depositary Shares on The Nasdaq Stock Market, LLC.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).&#160;</span></div><div><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Emerging growth company <ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-true" id="f-26">&#9746;</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <ix:nonNumeric contextRef="c-1" name="dei:EntityExTransitionPeriod" format="ixt:fixed-false" id="f-27">&#9744;</ix:nonNumeric></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div id="i4bba4f261f6b44bcb1314598cee902ad_7"></div><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.02&#160;&#160;&#160;&#160;Results of Operations and Financial Condition.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 14, 2025, Centessa Pharmaceuticals plc (the &#8220;Company&#8221;) announced its financial results for the three months ended March 31, 2025. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K.</span></div><div style="margin-bottom:18pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The information in this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div id="i4bba4f261f6b44bcb1314598cee902ad_10"></div><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01&#160;&#160;&#160;&#160;Financial Statements and Exhibits.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Exhibits</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:5.771%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:92.029%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit No.</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="cntapr-q12025.htm">Press Release dated May 14, 2025</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Cover Page Interactive Data (embedded within the Inline XBRL document)</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="i4bba4f261f6b44bcb1314598cee902ad_13"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div><span><br/></span></div><div style="text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div><span><br/></span></div><div style="text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Date:&#160;&#160;&#160;May&#160;14, 2025</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.999%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:41.591%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Saurabh Saha</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Saurabh Saha, M.D., Ph.D.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>cntapr-q12025.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="icea342b3419f4f38b96bd8b0a2c8f219_1"></div><div style="min-height:94.32pt;width:100%"><div style="margin-bottom:8pt;text-align:center"><img alt="letterheada.jpg" src="letterheada.jpg" style="height:89px;margin-bottom:5pt;vertical-align:text-bottom;width:246px"></div></div><div style="text-align:right"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%"> Exhibit 99.1</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Centessa Pharmaceuticals Reports Financial Results and Business Highlights </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">for the First Quarter of 2025 </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:150%">Advancing a broad, potential best-in-class orexin receptor 2 (OX2R) agonist franchise, with key data readouts expected this year</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:150%;padding-left:13.8pt">ORX750 Phase 2a CRYSTAL-1 study for the treatment of narcolepsy type 1 (NT1), narcolepsy type 2 (NT2) and idiopathic hypersomnia (IH) on track with data expected across all three indications this year with first-in-class potential in NT2 and IH</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:150%;padding-left:13.8pt">ORX142 on track to initiate first-in-human studies for the treatment of neurological and neurodegenerative disorders with clinical data in acutely sleep-deprived healthy volunteers planned for this year</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:150%;padding-left:13.8pt">ORX489 advancing in IND-enabling studies for the treatment of neuropsychiatric disorders</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:150%">BOSTON and LONDON, May 14, 2025</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:150%"> --</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:150%"> </font><font style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:150%;text-decoration:underline">Centessa Pharmaceuticals plc</font><font style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:150%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:150%">(Nasdaq&#58; CNTA), a clinical-stage pharmaceutical company, today reported financial results and business highlights for the first quarter ended March 31, 2025. </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:150%">&#8220;This was a productive quarter for Centessa, marked by steady progress across our OX2R agonist pipeline,&#8221; said Saurabh Saha MD PhD, Chief Executive Officer of Centessa. &#8220;The orexin pathway represents a promising new frontier in neuroscience, with the potential to address not only sleep-wake disorders, but also excessive daytime sleepiness in a broad spectrum of neurological, neurodegenerative and neuropsychiatric disorders, as well as impaired attention, cognitive deficits and fatigue.&#8221;</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:150%">Dr. Saha continued, &#8220;We are excited to be at the forefront of developing OX2R agonists starting with ORX750, our most advanced OX2R agonist for the treatment of NT1, NT2 and IH. ORX750 is progressing in the Phase 2a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:150%">CRYSTAL-1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:150%"> study and is on track with patient data expected across all three indications this year. Given the unmet patient need for new treatment options, the team is intensely focused on execution to carry this momentum forward into registrational studies, as quickly as possible.&#8221;</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:150%">&#8220;In parallel, we continue to advance our pipeline of potential first-in-class follow-up OX2R agonists for the treatment of neurological, neurodegenerative and neuropsychiatric disorders. More specifically, we are on track to initiate first-in-human studies of ORX142 with clinical data in acutely sleep-deprived healthy volunteers planned for this year. With multiple data readouts expected across our OX2R agonist pipeline, we believe this will be another transformative year for Centessa and for the OX2R agonist class overall,&#8221; said Dr. Saha.</font></div><div><font><br></font></div><div style="height:103.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:94.32pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:150%">Recent Highlights</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:150%;padding-left:13.8pt">In April 2025, additional data from the Phase 1 study of ORX750 were presented in a poster session at the American Academy of Neurology (AAN) Annual Meeting. In addition to showing previously disclosed Phase 1 data, the poster featured the time-course curves of the Maintenance of Wakefulness Test (MWT) and Karolinska Sleepiness Scale (KSS) results from the 5.0 mg dose cohort. These data showed that at the 5.0 mg dose sustained effects were observed throughout the 8-hour post dose observation period in both mean sleep latency on the MWT (&#62;30 minutes) and in KSS scores, compared to placebo. The Company believes that the totality of the Phase 1 data continues to support ORX750&#8217;s profile as a potential best-in-class OX2R agonist for the treatment of NT1, NT2 and IH, with first-in-class potential in NT2 and IH. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:150%">OX2R Agonist Pipeline and Anticipated Upcoming Milestones</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:150%">  </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:150%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:150%;padding-left:13.8pt">ORX750</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:150%">&#58; The Phase 2a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:150%">CRYSTAL-1 </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:150%">study is ongoing in participants with NT1, NT2 and IH, with data from all three indications planned in 2025.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:150%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:150%;padding-left:13.8pt">ORX142</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:150%">&#58; Subject to IND clearance, the Company plans to initiate first-in-human studies with the goal of sharing clinical data in acutely sleep-deprived healthy volunteers in 2025.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:150%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:150%;padding-left:13.8pt">ORX489</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:150%">&#58; Currently in IND-enabling studies. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:150%">First Quarter 2025 Financial Results</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:150%;padding-left:13.8pt">Cash, Cash Equivalents and Investments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:150%">&#58; </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:150%">Cash, cash equivalents and investments totaled </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:150%">$424.9 million</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:150%"> as of March 31, 2025. The Company expects its cash, cash equivalents and investments as of March 31, 2025 will fund operations into mid-2027.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:150%;padding-left:13.8pt">Research &#38; Development (R&#38;D) Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:150%">&#58; </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:150%">R&#38;D expenses were </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:150%">$33.4 million</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:150%"> for the first quarter ended March 31, 2025, compared to </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:150%">$22.7 million</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:150%"> for the first quarter ended March 31, 2024.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:150%;padding-left:13.8pt">General &#38; Administrative (G&#38;A) Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:150%">&#58; G&#38;A expenses were </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:150%">$12.3 million</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:150%"> for the first quarter ended March 31, 2025, compared to </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:150%">$13.4 million</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:150%"> for the first quarter ended March 31, 2024.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:150%;padding-left:13.8pt">Net Loss Attributable to Ordinary Shareholders (Net loss)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:150%">&#58; Net loss was </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:150%">$26.1 million</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:150%"> for the first quarter ended March 31, 2025, compared to </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:150%">$38.0 million</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:150%"> for the first quarter ended March 31, 2024.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:150%">About Phase 2a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:150%">CRYSTAL-1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:150%"> Clinical Study of ORX750 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:150%"> </font></div><div style="margin-top:6pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:150%">The Phase 2a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:150%">CRYSTAL-1</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:150%"> study is a randomized, double-blind, placebo-controlled, cross-over basket study to evaluate the safety, tolerability and pharmacokinetics (PK) of ORX750 in participants with NT1, NT2 and IH. Efficacy assessments will evaluate the effect of ORX750 on excessive daytime sleepiness (using the MWT and Epworth Sleepiness Scale (ESS)), cataplexy (NT1 only) and overall symptom improvement (measured by Narcolepsy Severity Scale (NSS) and Idiopathic Hypersomnia Severity Scale (IHSS)). Other exploratory </font></div><div style="height:103.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:94.32pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-top:6pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:150%">assessments include measures of sleep, cognition, attention, memory and general health. For more information, visit </font><font style="background-color:#ffffff;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:150%">https&#58;&#47;&#47;clinicaltrials.gov&#47;study&#47;NCT06752668</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:150%">.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:150%">About Centessa Pharmaceuticals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:150%"> </font></div><div><font style="background-color:#ffffff;color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:150%;text-decoration:underline">Centessa Pharmaceuticals, plc</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:150%"> is a clinical-stage pharmaceutical company with a mission to discover, develop and ultimately deliver medicines that are transformational for patients. We are pioneering a new class of potential therapies within our orexin receptor 2 (OX2R) agonist program for the treatment of excessive daytime sleepiness (EDS), impaired attention, cognitive deficits and fatigue across neurological, neurodegenerative and neuropsychiatric disorders. We also have an early-stage immuno-oncology program focused on our novel LockBody</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:150%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:150%"> technology platform. For more information, visit www.centessa.com, which does not form part of this release.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Forward Looking Statements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:174%">  </font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:174%">This press release contains forward-looking statements. These statements may be identified by words such as &#8220;may,&#8221; &#8220;might,&#8221; &#8220;will,&#8221; &#8220;could,&#8221; &#8220;would,&#8221; &#8220;should,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;objective,&#8221; &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;predict,&#8221; &#8220;potential,&#8221; &#8220;continue,&#8221; &#8220;ongoing,&#8221; &#8220;aim,&#8221; &#8220;seek,&#8221; and variations of these words or similar expressions that are intended to identify forward-looking statements. Any such statements in this press release that are not statements of historical fact may be deemed to be forward-looking statements, including statements related to the Company&#8217;s ability to discover and develop transformational medicines for patients&#59; its expectations for executing on the Company's pipeline&#59; its expectations on its anticipated cash runway&#59; the timing of commencement of new studies or clinical trials or clinical and preclinical data related to ORX750, ORX142, ORX489 and other OX2R agonist molecules, and the LockBody technology platform&#59; its ability to identify, screen, recruit and maintain a sufficient number of or any subjects in its existing and anticipated studies or clinical trials of ORX750, ORX142, ORX489 and other OX2R agonist molecules, and any LockBody candidates&#59; its expectations on executing its research and clinical development plans and the timing thereof&#59; its expectations as to the potential results and impact of each of its clinical programs and trials&#59; the Company&#8217;s ability to differentiate ORX750, ORX142, ORX489 and other OX2R agonist molecules, any LockBody candidates from other treatment options&#59; the development, design and therapeutic potential of ORX750, ORX142, ORX489 and other OX2R agonist molecules, and the LockBody technology platform&#59; and regulatory matters, including the timing and likelihood of success of obtaining regulatory clearance, obtaining authorizations to initiate or continue clinical trials. Any forward-looking statements in this press release are based on our current expectations, estimates, assumptions and projections only as of the date of this release and are subject to a number of risks and uncertainties that could cause actual results to differ materially and adversely from those set forth in or implied by such forward-looking statements. These risks </font></div><div style="height:103.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:94.32pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:174%">and uncertainties include, but are not limited to, risks related to the safety and tolerability profile of our product candidates&#59; our ability to identify, screen and recruit a sufficient number of or any subjects in our existing and anticipated new studies or clinical trials of ORX750, ORX142, ORX489 or within anticipated timelines&#59; our expectations relating to the clinical trials of ORX750, including the predicted timing of enrollment, the predicted efficacious doses of ORX750 and our ability to successfully conduct our clinical development of ORX750, our ability to protect and maintain our intellectual property position&#59; business (including commercial viability), regulatory, economic and competitive risks, uncertainties, contingencies and assumptions about the Company&#59; risks inherent in developing product candidates and technologies&#59; future results from our ongoing and planned clinical trials&#59; our ability to obtain adequate financing, including through our financing facility with Oxford Finance, to fund our planned clinical trials and other expenses&#59; trends in the industry&#59; the legal and regulatory framework for the industry, including the receipt and maintenance of clearances to conduct or continue clinical testing&#59; our operating costs and use of cash, including cash runway, cost of development activities and conducting clinical trials, future expenditures risks&#59; the risk that any one or more of our product candidates will not be successfully developed and&#47;or commercialized&#59; the risk that the historical results of preclinical studies or clinical studies will not be predictive of future results in ongoing or future studies&#59; economic risks to the United States and United Kingdom banking systems&#59; and geo-political risks such as the Russia-Ukraine war, the Middle East conflicts or trade wars and imposition of tariffs. These and other risks concerning our programs and operations are described in additional detail in our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and our other reports, which are on file with the U.S. Securities and Exchange Commission (SEC). We explicitly disclaim any obligation to update any forward-looking statements except to the extent required by law.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Contact&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Kristen K. Sheppard, Esq.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:174%">SVP of Investor Relations</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">investors&#64;centessa.com</font></div><div><font><br></font></div><div style="height:103.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:94.32pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Centessa Pharmaceuticals plc</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Operations and Comprehensive Loss</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(unaudited)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(amounts in thousands except share and per share data)</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.791%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">Three Months Ended<br>March 31, 2025</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">Three Months Ended<br>March 31, 2024</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">License and other revenue</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">15,000&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Operating expenses&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Research and development</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">33,443&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">22,652&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">General and administrative</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">12,334&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">13,438&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Loss from operations</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(30,777)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(36,090)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Interest and investment income</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">7,890&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">2,591&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Interest expense</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(2,877)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(2,529)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Other non-operating income (expense), net</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1,026&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(1,537)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Loss before income taxes</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(24,738)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(37,565)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Income tax expense</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1,397&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">481&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Net loss</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(26,135)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(38,046)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Other comprehensive (loss) income&#58;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Foreign currency translation adjustment</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">643&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(25)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Unrealized gain on available for sale marketable securities, net of reclassification adjustment and tax</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(2,781)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">155&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Other comprehensive (loss) income</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(2,138)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">130&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Total comprehensive loss</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(28,273)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(37,916)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Net loss per ordinary share - basic and diluted</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(0.20)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(0.38)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Weighted average ordinary shares outstanding - basic and diluted</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">133,033,541&#160;</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">99,887,720&#160;</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:103.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:94.32pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Centessa Pharmaceuticals plc</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Balance Sheets</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(unaudited)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(amounts in thousands)</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.174%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.300%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">March 31, 2025</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">December 31, 2024</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Total assets&#58;</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Cash and cash equivalents</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">105,156&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">383,221&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Investments in marketable securities</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">319,744&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">98,956&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Other assets</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">102,945&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">94,621&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Total assets</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">527,845&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">576,798&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Total liabilities</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Other liabilities</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">32,346&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">66,313&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Long term debt</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">109,252&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">108,940&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Total liabilities</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">141,598&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">175,253&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Total shareholders&#8217; equity</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">386,247&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">401,545&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Total liabilities and shareholders' equity</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">527,845&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">576,798&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:103.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>cnta-20250514.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:933a1ab4-4bc8-4269-b782-1ba9a40db680,g:18cc038a-1bac-4078-bb61-becd6ee8e29c-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cnta="http://www.cnta.com/20250514" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types1="http://www.xbrl.org/dtr/type/2020-01-21" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.cnta.com/20250514">
  <xs:import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cnta-20250514_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cnta-20250514_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cnta-20250514_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.cnta.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="cnta_AmericanDepositarySharesMember" abstract="true" name="AmericanDepositarySharesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>cnta-20250514_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:933a1ab4-4bc8-4269-b782-1ba9a40db680,g:18cc038a-1bac-4078-bb61-becd6ee8e29c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.cnta.com/role/Cover" xlink:type="simple" xlink:href="cnta-20250514.xsd#Cover"/>
  <link:definitionLink xlink:role="http://www.cnta.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_312505c9-f2b9-4bd6-bf60-c05983c529af" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_c6391e7b-81a3-4a32-bf8d-2b5813c4ebed" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_DocumentInformationLineItems_312505c9-f2b9-4bd6-bf60-c05983c529af" xlink:to="loc_dei_DocumentInformationTable_c6391e7b-81a3-4a32-bf8d-2b5813c4ebed" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_cae5d1ac-c61a-4bd1-a16e-7320ab492086" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_DocumentInformationTable_c6391e7b-81a3-4a32-bf8d-2b5813c4ebed" xlink:to="loc_us-gaap_StatementClassOfStockAxis_cae5d1ac-c61a-4bd1-a16e-7320ab492086" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_cae5d1ac-c61a-4bd1-a16e-7320ab492086_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_cae5d1ac-c61a-4bd1-a16e-7320ab492086" xlink:to="loc_us-gaap_ClassOfStockDomain_cae5d1ac-c61a-4bd1-a16e-7320ab492086_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_55a18409-ebbe-466c-95af-88f0ffdd0264" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_cae5d1ac-c61a-4bd1-a16e-7320ab492086" xlink:to="loc_us-gaap_ClassOfStockDomain_55a18409-ebbe-466c-95af-88f0ffdd0264" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_808a32b0-2013-43c6-af7b-a0fba39a6a91" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_55a18409-ebbe-466c-95af-88f0ffdd0264" xlink:to="loc_us-gaap_CommonStockMember_808a32b0-2013-43c6-af7b-a0fba39a6a91" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnta_AmericanDepositarySharesMember_d7cefad4-0230-46b0-aa5c-1f98e7de7989" xlink:href="cnta-20250514.xsd#cnta_AmericanDepositarySharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_55a18409-ebbe-466c-95af-88f0ffdd0264" xlink:to="loc_cnta_AmericanDepositarySharesMember_d7cefad4-0230-46b0-aa5c-1f98e7de7989" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_10ae00d3-7e7b-4ad1-a10f-1bc7a714243d" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_312505c9-f2b9-4bd6-bf60-c05983c529af" xlink:to="loc_dei_DocumentType_10ae00d3-7e7b-4ad1-a10f-1bc7a714243d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_4b3c3633-fe87-4ad6-96c2-3fbf6cee32c2" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_312505c9-f2b9-4bd6-bf60-c05983c529af" xlink:to="loc_dei_DocumentPeriodEndDate_4b3c3633-fe87-4ad6-96c2-3fbf6cee32c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_70a77f1b-c453-4a87-a704-1d585a8754f4" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_312505c9-f2b9-4bd6-bf60-c05983c529af" xlink:to="loc_dei_EntityRegistrantName_70a77f1b-c453-4a87-a704-1d585a8754f4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_ed4f36d8-d944-4585-b7a3-225ccc970aa5" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_312505c9-f2b9-4bd6-bf60-c05983c529af" xlink:to="loc_dei_EntityIncorporationStateCountryCode_ed4f36d8-d944-4585-b7a3-225ccc970aa5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_67790e5a-2bdc-49cc-a8e9-89148521c960" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_312505c9-f2b9-4bd6-bf60-c05983c529af" xlink:to="loc_dei_EntityFileNumber_67790e5a-2bdc-49cc-a8e9-89148521c960" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_15551348-1646-476c-9786-b87efc25e503" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_312505c9-f2b9-4bd6-bf60-c05983c529af" xlink:to="loc_dei_EntityAddressAddressLine1_15551348-1646-476c-9786-b87efc25e503" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_7d4216cc-246d-4774-a9bc-4402f7580a35" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_312505c9-f2b9-4bd6-bf60-c05983c529af" xlink:to="loc_dei_EntityAddressAddressLine2_7d4216cc-246d-4774-a9bc-4402f7580a35" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine3_19b24a1a-5a9d-40e3-be6d-b07208fe91a3" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_312505c9-f2b9-4bd6-bf60-c05983c529af" xlink:to="loc_dei_EntityAddressAddressLine3_19b24a1a-5a9d-40e3-be6d-b07208fe91a3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_202ee057-bd90-47ce-8745-36e23332866f" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_312505c9-f2b9-4bd6-bf60-c05983c529af" xlink:to="loc_dei_EntityAddressCityOrTown_202ee057-bd90-47ce-8745-36e23332866f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_9592f531-6f3f-4dbd-9b6f-7b6239a64a73" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_312505c9-f2b9-4bd6-bf60-c05983c529af" xlink:to="loc_dei_EntityAddressPostalZipCode_9592f531-6f3f-4dbd-9b6f-7b6239a64a73" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry_a8525496-fe3c-4997-b5ea-58fc70c791b1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_312505c9-f2b9-4bd6-bf60-c05983c529af" xlink:to="loc_dei_EntityAddressCountry_a8525496-fe3c-4997-b5ea-58fc70c791b1" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CountryRegion_81a36834-53dc-4af0-b059-61b073d12dc1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_312505c9-f2b9-4bd6-bf60-c05983c529af" xlink:to="loc_dei_CountryRegion_81a36834-53dc-4af0-b059-61b073d12dc1" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_fd3f27a3-eaea-46fb-839b-adc58f8be4e4" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_312505c9-f2b9-4bd6-bf60-c05983c529af" xlink:to="loc_dei_CityAreaCode_fd3f27a3-eaea-46fb-839b-adc58f8be4e4" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_ab29f814-7840-4dc0-991e-b5689f4b1a2e" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_312505c9-f2b9-4bd6-bf60-c05983c529af" xlink:to="loc_dei_LocalPhoneNumber_ab29f814-7840-4dc0-991e-b5689f4b1a2e" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_9eaeb4d5-a6e2-4d95-b67f-16260ca5711a" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_312505c9-f2b9-4bd6-bf60-c05983c529af" xlink:to="loc_dei_WrittenCommunications_9eaeb4d5-a6e2-4d95-b67f-16260ca5711a" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_f763e3ae-47bb-45fc-94f6-917ffe74cafb" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_312505c9-f2b9-4bd6-bf60-c05983c529af" xlink:to="loc_dei_SolicitingMaterial_f763e3ae-47bb-45fc-94f6-917ffe74cafb" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_2656c3e5-21a3-4f53-baaa-667a6f0316ad" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_312505c9-f2b9-4bd6-bf60-c05983c529af" xlink:to="loc_dei_PreCommencementTenderOffer_2656c3e5-21a3-4f53-baaa-667a6f0316ad" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_ba2566c9-3aa5-4068-8caf-995292920bbb" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_312505c9-f2b9-4bd6-bf60-c05983c529af" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_ba2566c9-3aa5-4068-8caf-995292920bbb" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_e7bdbe45-3244-4f9e-9b1c-0db5ae337ba9" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_312505c9-f2b9-4bd6-bf60-c05983c529af" xlink:to="loc_dei_Security12bTitle_e7bdbe45-3244-4f9e-9b1c-0db5ae337ba9" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_04bc00d7-eac7-461a-8409-5f114b56e39b" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_312505c9-f2b9-4bd6-bf60-c05983c529af" xlink:to="loc_dei_TradingSymbol_04bc00d7-eac7-461a-8409-5f114b56e39b" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_cce35211-4754-49d6-b6d0-b4d72fc1c387" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_312505c9-f2b9-4bd6-bf60-c05983c529af" xlink:to="loc_dei_SecurityExchangeName_cce35211-4754-49d6-b6d0-b4d72fc1c387" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_cdba03dc-18e2-4b07-8a21-4067839bbc50" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_312505c9-f2b9-4bd6-bf60-c05983c529af" xlink:to="loc_dei_EntityEmergingGrowthCompany_cdba03dc-18e2-4b07-8a21-4067839bbc50" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod_46621581-6c59-4cd7-b010-f91ab2880762" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_312505c9-f2b9-4bd6-bf60-c05983c529af" xlink:to="loc_dei_EntityExTransitionPeriod_46621581-6c59-4cd7-b010-f91ab2880762" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_48e3b737-b60a-4d1c-bef9-705a7dc7cbfd" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_312505c9-f2b9-4bd6-bf60-c05983c529af" xlink:to="loc_dei_AmendmentFlag_48e3b737-b60a-4d1c-bef9-705a7dc7cbfd" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_dceec896-1255-404c-821a-38336dd4420c" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_312505c9-f2b9-4bd6-bf60-c05983c529af" xlink:to="loc_dei_EntityCentralIndexKey_dceec896-1255-404c-821a-38336dd4420c" xlink:type="arc" order="24"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>cnta-20250514_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:933a1ab4-4bc8-4269-b782-1ba9a40db680,g:18cc038a-1bac-4078-bb61-becd6ee8e29c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_ClassOfStockDomain_f465d5b4-dde2-47a3-baaf-205cacb2276c_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_d1bac068-8ce3-470a-bab0-4f549efe6e36_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_32095956-16f1-4c2a-9a6a-13c0e248aa9b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_676254fb-2de8-494a-a01a-c58f4b480e27_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityExTransitionPeriod_12b7ad48-c83b-4241-aeae-2e10d5536432_terseLabel_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:label id="lab_dei_EntityExTransitionPeriod_label_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityExTransitionPeriod" xlink:to="lab_dei_EntityExTransitionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_fa05f228-f934-4924-84be-774321a413f7_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_d1548ba7-30ad-47ff-99a0-5a1e5be8f883_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_969b70fe-d7d6-4dcd-9bf2-879de9237883_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_599acc7f-bf74-4229-a101-ad45332d6991_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Ordinary shares</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_5b6d1d3d-6d48-44e1-9826-2c5c6a450b85_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_a609a486-1d09-4928-a1cb-240d7eeb7408_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_aab5cc24-4968-4015-a342-181c58eeb7c8_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_1e405391-0ba7-4ff5-ac13-f052edbd4c7c_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_ca5cf50b-b92c-4633-90bf-2d38eed24f7c_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_cnta_AmericanDepositarySharesMember_066b8104-d8ed-4b1d-8c35-a68034921dfe_terseLabel_en-US" xlink:label="lab_cnta_AmericanDepositarySharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">American Depositary Shares</link:label>
    <link:label id="lab_cnta_AmericanDepositarySharesMember_label_en-US" xlink:label="lab_cnta_AmericanDepositarySharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">American Depositary Shares [Member]</link:label>
    <link:label id="lab_cnta_AmericanDepositarySharesMember_documentation_en-US" xlink:label="lab_cnta_AmericanDepositarySharesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">American Depositary Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnta_AmericanDepositarySharesMember" xlink:href="cnta-20250514.xsd#cnta_AmericanDepositarySharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnta_AmericanDepositarySharesMember" xlink:to="lab_cnta_AmericanDepositarySharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_27c1ef9b-23ba-4451-8b33-f85298013d50_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCountry_e23ceea6-b60d-40db-aafb-35aa2b2d2748_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Country</link:label>
    <link:label id="lab_dei_EntityAddressCountry_label_en-US" xlink:label="lab_dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Country</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCountry" xlink:to="lab_dei_EntityAddressCountry" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_483fa34d-1d22-40c7-a67d-e259abf7898c_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_fc30fd44-9776-419f-9984-722c67db7358_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_a5b632a5-a06a-4a9a-a0dc-3d90518386d5_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_92bd97e3-b779-4bec-a64b-d955c1b719eb_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationLineItems_018c8bcc-a7d3-40fa-a7e0-c883f9735dbd_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:label id="lab_dei_DocumentInformationLineItems_label_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="lab_dei_DocumentInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationTable_f4e72119-bd4c-46e6-aada-2e896cc64627_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
    <link:label id="lab_dei_DocumentInformationTable_label_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationTable" xlink:to="lab_dei_DocumentInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_5663e0b3-da95-4d72-80fb-a07129e924d8_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine3_1a74d61b-ce7d-438d-9055-5890c317bb84_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Three</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine3_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine3" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine3" xlink:to="lab_dei_EntityAddressAddressLine3" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_a960deb7-db02-41f8-ab69-e402022476f2_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_2ada3584-41d2-4166-81b4-cf5a3c25f41c_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_e9fda2b9-ab15-4b0a-9d62-6c60f4498a7d_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CountryRegion_77198c3a-e471-4bf7-ac21-c374a428da82_terseLabel_en-US" xlink:label="lab_dei_CountryRegion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Country Region</link:label>
    <link:label id="lab_dei_CountryRegion_label_en-US" xlink:label="lab_dei_CountryRegion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Country Region</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CountryRegion" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CountryRegion" xlink:to="lab_dei_CountryRegion" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_ccf41158-493e-40b7-826a-ea27b1039928_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_43634003-5c37-44ce-b182-db027ae9afd7_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_6c01dc67-1d85-4d9f-90cb-13adbde50415_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>cnta-20250514_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:933a1ab4-4bc8-4269-b782-1ba9a40db680,g:18cc038a-1bac-4078-bb61-becd6ee8e29c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.cnta.com/role/Cover" xlink:type="simple" xlink:href="cnta-20250514.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.cnta.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_4e52483b-8ae6-4a37-b843-32102f6adf63" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_c6391e7b-81a3-4a32-bf8d-2b5813c4ebed" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4e52483b-8ae6-4a37-b843-32102f6adf63" xlink:to="loc_dei_DocumentInformationTable_c6391e7b-81a3-4a32-bf8d-2b5813c4ebed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_cae5d1ac-c61a-4bd1-a16e-7320ab492086" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_c6391e7b-81a3-4a32-bf8d-2b5813c4ebed" xlink:to="loc_us-gaap_StatementClassOfStockAxis_cae5d1ac-c61a-4bd1-a16e-7320ab492086" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_55a18409-ebbe-466c-95af-88f0ffdd0264" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_cae5d1ac-c61a-4bd1-a16e-7320ab492086" xlink:to="loc_us-gaap_ClassOfStockDomain_55a18409-ebbe-466c-95af-88f0ffdd0264" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_808a32b0-2013-43c6-af7b-a0fba39a6a91" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_55a18409-ebbe-466c-95af-88f0ffdd0264" xlink:to="loc_us-gaap_CommonStockMember_808a32b0-2013-43c6-af7b-a0fba39a6a91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnta_AmericanDepositarySharesMember_d7cefad4-0230-46b0-aa5c-1f98e7de7989" xlink:href="cnta-20250514.xsd#cnta_AmericanDepositarySharesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_55a18409-ebbe-466c-95af-88f0ffdd0264" xlink:to="loc_cnta_AmericanDepositarySharesMember_d7cefad4-0230-46b0-aa5c-1f98e7de7989" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_312505c9-f2b9-4bd6-bf60-c05983c529af" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_c6391e7b-81a3-4a32-bf8d-2b5813c4ebed" xlink:to="loc_dei_DocumentInformationLineItems_312505c9-f2b9-4bd6-bf60-c05983c529af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_10ae00d3-7e7b-4ad1-a10f-1bc7a714243d" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_312505c9-f2b9-4bd6-bf60-c05983c529af" xlink:to="loc_dei_DocumentType_10ae00d3-7e7b-4ad1-a10f-1bc7a714243d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_4b3c3633-fe87-4ad6-96c2-3fbf6cee32c2" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_312505c9-f2b9-4bd6-bf60-c05983c529af" xlink:to="loc_dei_DocumentPeriodEndDate_4b3c3633-fe87-4ad6-96c2-3fbf6cee32c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_70a77f1b-c453-4a87-a704-1d585a8754f4" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_312505c9-f2b9-4bd6-bf60-c05983c529af" xlink:to="loc_dei_EntityRegistrantName_70a77f1b-c453-4a87-a704-1d585a8754f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_ed4f36d8-d944-4585-b7a3-225ccc970aa5" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_312505c9-f2b9-4bd6-bf60-c05983c529af" xlink:to="loc_dei_EntityIncorporationStateCountryCode_ed4f36d8-d944-4585-b7a3-225ccc970aa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_67790e5a-2bdc-49cc-a8e9-89148521c960" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_312505c9-f2b9-4bd6-bf60-c05983c529af" xlink:to="loc_dei_EntityFileNumber_67790e5a-2bdc-49cc-a8e9-89148521c960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_15551348-1646-476c-9786-b87efc25e503" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_312505c9-f2b9-4bd6-bf60-c05983c529af" xlink:to="loc_dei_EntityAddressAddressLine1_15551348-1646-476c-9786-b87efc25e503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_7d4216cc-246d-4774-a9bc-4402f7580a35" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_312505c9-f2b9-4bd6-bf60-c05983c529af" xlink:to="loc_dei_EntityAddressAddressLine2_7d4216cc-246d-4774-a9bc-4402f7580a35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine3_19b24a1a-5a9d-40e3-be6d-b07208fe91a3" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_312505c9-f2b9-4bd6-bf60-c05983c529af" xlink:to="loc_dei_EntityAddressAddressLine3_19b24a1a-5a9d-40e3-be6d-b07208fe91a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_202ee057-bd90-47ce-8745-36e23332866f" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_312505c9-f2b9-4bd6-bf60-c05983c529af" xlink:to="loc_dei_EntityAddressCityOrTown_202ee057-bd90-47ce-8745-36e23332866f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_9592f531-6f3f-4dbd-9b6f-7b6239a64a73" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_312505c9-f2b9-4bd6-bf60-c05983c529af" xlink:to="loc_dei_EntityAddressPostalZipCode_9592f531-6f3f-4dbd-9b6f-7b6239a64a73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry_a8525496-fe3c-4997-b5ea-58fc70c791b1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_312505c9-f2b9-4bd6-bf60-c05983c529af" xlink:to="loc_dei_EntityAddressCountry_a8525496-fe3c-4997-b5ea-58fc70c791b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CountryRegion_81a36834-53dc-4af0-b059-61b073d12dc1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_312505c9-f2b9-4bd6-bf60-c05983c529af" xlink:to="loc_dei_CountryRegion_81a36834-53dc-4af0-b059-61b073d12dc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_fd3f27a3-eaea-46fb-839b-adc58f8be4e4" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_312505c9-f2b9-4bd6-bf60-c05983c529af" xlink:to="loc_dei_CityAreaCode_fd3f27a3-eaea-46fb-839b-adc58f8be4e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_ab29f814-7840-4dc0-991e-b5689f4b1a2e" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_312505c9-f2b9-4bd6-bf60-c05983c529af" xlink:to="loc_dei_LocalPhoneNumber_ab29f814-7840-4dc0-991e-b5689f4b1a2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_9eaeb4d5-a6e2-4d95-b67f-16260ca5711a" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_312505c9-f2b9-4bd6-bf60-c05983c529af" xlink:to="loc_dei_WrittenCommunications_9eaeb4d5-a6e2-4d95-b67f-16260ca5711a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_f763e3ae-47bb-45fc-94f6-917ffe74cafb" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_312505c9-f2b9-4bd6-bf60-c05983c529af" xlink:to="loc_dei_SolicitingMaterial_f763e3ae-47bb-45fc-94f6-917ffe74cafb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_2656c3e5-21a3-4f53-baaa-667a6f0316ad" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_312505c9-f2b9-4bd6-bf60-c05983c529af" xlink:to="loc_dei_PreCommencementTenderOffer_2656c3e5-21a3-4f53-baaa-667a6f0316ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_ba2566c9-3aa5-4068-8caf-995292920bbb" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_312505c9-f2b9-4bd6-bf60-c05983c529af" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_ba2566c9-3aa5-4068-8caf-995292920bbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_e7bdbe45-3244-4f9e-9b1c-0db5ae337ba9" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_312505c9-f2b9-4bd6-bf60-c05983c529af" xlink:to="loc_dei_Security12bTitle_e7bdbe45-3244-4f9e-9b1c-0db5ae337ba9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_04bc00d7-eac7-461a-8409-5f114b56e39b" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_312505c9-f2b9-4bd6-bf60-c05983c529af" xlink:to="loc_dei_TradingSymbol_04bc00d7-eac7-461a-8409-5f114b56e39b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_cce35211-4754-49d6-b6d0-b4d72fc1c387" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_312505c9-f2b9-4bd6-bf60-c05983c529af" xlink:to="loc_dei_SecurityExchangeName_cce35211-4754-49d6-b6d0-b4d72fc1c387" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_cdba03dc-18e2-4b07-8a21-4067839bbc50" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_312505c9-f2b9-4bd6-bf60-c05983c529af" xlink:to="loc_dei_EntityEmergingGrowthCompany_cdba03dc-18e2-4b07-8a21-4067839bbc50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod_46621581-6c59-4cd7-b010-f91ab2880762" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_312505c9-f2b9-4bd6-bf60-c05983c529af" xlink:to="loc_dei_EntityExTransitionPeriod_46621581-6c59-4cd7-b010-f91ab2880762" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_48e3b737-b60a-4d1c-bef9-705a7dc7cbfd" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_312505c9-f2b9-4bd6-bf60-c05983c529af" xlink:to="loc_dei_AmendmentFlag_48e3b737-b60a-4d1c-bef9-705a7dc7cbfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_dceec896-1255-404c-821a-38336dd4420c" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_312505c9-f2b9-4bd6-bf60-c05983c529af" xlink:to="loc_dei_EntityCentralIndexKey_dceec896-1255-404c-821a-38336dd4420c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_35d8e27e-af21-406a-a1b3-332057d24a30" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4e52483b-8ae6-4a37-b843-32102f6adf63" xlink:to="loc_dei_EntityTaxIdentificationNumber_35d8e27e-af21-406a-a1b3-332057d24a30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>letterheada.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 letterheada.jpg
M_]C_X  02D9)1@ ! 0$"6 )8  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" (>!=P# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?^9^VY#GT,TA[*KI57X^:_5?H=]1117@'UX4444 %%%% !117@7[47[4>G?
MW1FTW36BO_&5W'FWM2=RVJGI-*/_ $%?XOI710H5,345*DKMG)B\71P5&5>O
M*T5_5EYB_M1?M1:=\#=&;3=-:*_\97<>;>U/S):J>DTH_DO\7TK\Q?$'B#4?
M%.LWFK:M>2W^HWDAEGN)FW.['N?\\4:_K^H^*=9O-6U:\EO]1NY#+/<3-N9V
M/4G_ #Q6?7Z=E^7T\!3LM9/=_P!=#\)SC.*V;5N:6D%LNWF_,***GL;&XU*\
M@M+6&2XNIW6**&)2S.S' 4 <DDG&*]0\ ](_9R^$<_QF^*FE:)Y;G3(W^U:C
M*O\ !;H06Y[%N%'NPK]<X(8[6&.&%%BBC4(B*,!5 P !Z8KQ;]E/X!Q? WX?
MJM[&C>)]4"SZC*N#Y?'R0 ^B9.?5BW;%>VU^99QCEC*]H/W8Z+]6?NG#F5O+
M<)S5%^\GJ_+LOE^;"BBBO"/K HK,U+Q-H^BG&H:K8V)]+FX2/^9JC:_$3PK>
M2;+?Q+I$S_W8[Z(G_P!"K)U:<79R5_4Z(X>M*/-&#:]&=#138Y%F0.C*Z-R&
M4Y!IU:G.%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MOTZ_X0/PU_T+ND_^ ,7_ ,31_P ('X:_Z%W2?_ &+_XFODO[7P7_ $"K\/\
M(_0_]7<S_P"@^7_DW_R1^8I_;-^,@Z^+Y1_VXVW_ ,:IO_#:'QB_Z'&3_P
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M"WAD@+P1HREF8'E%&> .M>;_ +6/[&=KX$TB[\9^!TD_L> [[_268N;92?\
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MQKZ]KR,ZS&56H\-2?NK?S?\ DCZ/A?)84*,<=75YRU7DN_J_R^84445\H?H
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MO]> ?L*_\FWZ!_U\W?\ Z/>O?Z_*\P_WNK_B?YG[[E'_ "+L/_@C^2"BBBN
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M_P#OE'_%'\T?K91117X\?TB%%%% !1110 4444 ?D#^TA_R7GQ[_ -AFZ_\
M1C5YO7I'[2'_ "7GQ[_V&;K_ -&-7F]?L>'_ (,/1?D?S7C/]YJ_XI?FS[E_
M9<_:O^'WPK^#.D^'=?O;R'4[>:X>1(;1G4!Y69<$=>"*]9_X;T^$O_01U'_P
M >OE;X*_L3ZG\9OA[8>*[;Q1::;%=22QBVEM7=EV.4Z@CKC/XUW7_#M36_\
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M[LUN^#CN".C ]P00:]D^._['/B[X/M<:E9(WB/PRN6^WVL9\R!<_\MH^2O\
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MBK<THNWR1^EE%%%?F9^YA1110 4444 %?-_[?G_)OT__ &$K?_V>OI"OF_\
M;]('[/TV3UU.WQ^3UZ66_P"^4O\ $CQ<Z_Y%N(_PO\C\R:]:_91_Y.(\#_\
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M_P!#/+_X+KG_ .-U^;_4,7_SZE]S/VQ9OE[5_K$/_ E_F>[T5X1_PV]\'?\
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M1M%(R.I5U."I&"#7TQ_P3W_Y+Y)_V"+C_P!"CK[#,O\ <ZOHS\VR7_D94/\
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MM;'<,'R(QM5L=MQRV.VZN&\(^%M1\;>)M-T+2;=KG4;^=8(8U[L3U/H!U)[
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MMG5;&0W3'V B#5Q1P]:3M&#?R9ZDL9AJ:O.K%+U1ZG7QQ_P4.^+=KI_A6P\
M64ZR:A?RI>7Z*<^5"AS&K>A9\-]$]Q5#XM?\%$K&&SGL?A_I4T]VP*C5=30*
MD?\ M)%DECZ;B/<&OA_7M?U+Q5K5WJVK7DVH:E=R&6>XG;<[L>Y/^< 5]7E.
M458U5B,0K);+K?\ 0_/^(.(\/4H2PF#ES.6C?1+JEWO]UC/K]!O^">OPBG\.
M^%]3\<ZC 8KC6 +6P5Q@BV5LN_T=P,?]<\]#7CO[,O[&6K_$:]M/$/B^VFTC
MPJC"1+>0%)[\#D!1U5#W;N/N]<C]&[&RM]-LX+2TACMK6WC6**&)0J(BC"J
M.@  &*USO,H.#PM)W;W_ ,CGX6R6HJJQ^(C9+X4^M^OIV[[D]%%4M9UFQ\/:
M5=ZGJ=U%8Z?:QM-/<3-M2- ,DDU\0DV[(_4VU%7>Q\V?M\?%@>"_A='X7LYM
MNJ>(F,;A3REJA!D/_ CM7W!?TK\X+&SFU&\@M;>-IIYG6..-!DLQ. ![DUZ)
M^T1\79OC3\4=4\0?.FG _9M/A?K';H2%X[$Y+$>K&F_LW-IJ?';P0VKO''9+
MJD+%I2 H<-F/.>V_;7ZA@,/_ &?@]5[UFWZ]OT/P;-L9_;&9:/W+J*]+VO\
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M**\D^A"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MOA/1+S5]7O(M/TVSC,L]Q,V%11_,]@!R20!S7YB?M0?M0:E\=-:.GZ>9=/\
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MSRDJ=T8=P?\  C! -??7PM^*6D_%3PZFH:>_E7,>%NK-FR\#_P!5/.&[^Q!
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MHH_M[&]U]P?ZI99VE]Y^</\ P[I^)'_04\._^!4W_P 9H_X=T_$C_H*>'?\
MP*F_^,U^CU%']O8WNON#_5++.TOO.$^!O@>_^&WPH\.^&M4D@EO]/@:.5[9B
MT9)D9N"0">&':N[HHKP:DW4FYRW;N?6T:4:%.-*&T4DOEH%<#\8?@GX:^.&A
MVVE^)$NO*M9#-!+:3>6\;D8)Y!!X]0:[ZBBG4G2DIP=F@K4:>(@Z56-XO=,^
M(/%'_!-:)F9_#OC-D7^&#4[3)_&1&_\ 9*\WU;_@GG\3;&1OLESH>HQ]C#=N
MC'\'1?YU^D]%>W3SS&PT<D_5?Y6/EZW"N5U7=0<?1O\ 6Y^7%Q^PQ\8+<_)X
M?MYAGK'J-O\ U<4R/]AWXQ2N%/AN)!_>;4;;'_HROU*HKI_UAQ?\L?N?^9Q?
MZFY??XY_>O\ Y$_-?1?^">OQ-U&1?ML^BZ5'_$9[MG8?@BM_.O8/ _\ P3AT
M+3Y(I_%?B:ZU4J<M:Z?$+>,^Q=BQ(^@4U]D45RU<[QM164N7T1W4.%\LHN[@
MY/S?Z*R.6\ _"_PK\+]-^P^&-$M=)A;'F-$N99<=WD.6;\374T45XDI2FW*;
MNSZFG3A2BH4TDET6B"BBBH-"*ZMX[RVE@E7=%*A1USC((P17R?XP_P""<_@W
M5GDE\/Z]J6A2-R(KA5NH@?8?*WYL:^M:*Z\/BZ^%;=&5KGG8S+\+F"2Q--2M
MMW7S6I^>&N_\$X?&UF6.E>(=$U%.WGF6!C^&QA^M<C=_L%_%NV;$>EV%U[PZ
MA$!_X\17Z>T5[$<_QD=[/Y?Y6/FZG".6S?N\T?1_YIGY9?\ #$/QC_Z%A/\
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M#\.8/"3]I0E*+\I/7U[H****\0^I"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH ***P/'3>(5\*W_P#PBJ6KZZ4Q;_;&VH">IZ$%@,X!XSC/
M%7"//)1O:_?8RJU/90E.S=E>RU;]%W/-/VAOVAK/X3Z:^F:8\=WXHN$_=Q\,
MMJI'$CCU]%_$\=?@;5M6O-<U*XO[^XDN[RX<R2S2L69F)R2375>/_ ?C?1]8
MN[OQ1I.HK=S.9);NX1G61B>3Y@RK?@:XS:<XQS7[!E6 H8*C^Z:DWO+O_P
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M+E(5_NC^\YYPOXG !-?J=\/OA]H?PP\*V?A_P]9K9Z?;#ZO*Y^]([?Q,>Y_
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MYEQ]X5K3ISK34*:NV85J]/#TW5K2Y8K=L]*HKYA_X>&_"_\ Y]/$/_@'%_\
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MC'=D3G&G%SF[):LWJ*^8?^'AOPO_ .?3Q#_X!Q?_ !VC_AX;\+_^?3Q#_P"
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MKA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MMS!ILKLL-M&PRF\ @LY!!(/ SC&1FO(O^"@5O+;_ +0%I-<HS6\FE6S1\<%
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MX[?\GY:?_P!AO1_Y6]?H]7YP?'!A<?MZ6*Q?O&77-(!"]B!;YHR/^-4_P/\
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M(5_NK_><]E_$X K]3? '@#1/AEX5L_#_ (?LULM.M5X'5Y&/WI';^)CW/X<
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M>TVWU73G97:VNDW(6'0X]J;X4\&Z)X%TG^S/#^F6^D:?O,OV>U3:FXXR<>O
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MQD<'3J.*?M)*R?9'SV99;/,JU%5&O90=VN[Z?+_-GB'_  [^^%?IK7_@:O\
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ML#7D0<QAL;L?7 _*O1R_%1P>)C6FKI7_ "/&SC SS+!3PU-I-VW\FF0_!_\
MY)-X*_[ ME_Z(2NNJOI^GVVDZ?;6-G"EM:6T2PPPQC"QHH 50/0  58KAG+F
MDY=SU*4'3IQ@^B2"BBBH-3S']HKX-P_'#X9WV@;T@U*-A=:?</T2=00 ?]E@
M64^F[/:OA[X*?M >*_V2]?U'PCXJT.YGTGSM\^G2G9-;R$8\R)CD$, ./NM@
M$$<D_I?7-^,OASX7^(=JEOXDT&QUF-/]6;J$,\?^ZWWE_ BO9P>/C1I2PV(A
MS4W]Z?D?,YEE-3$5XXW!U/9UHZ7Z-=G_ $_R/G'7?^"C7@6UTII-)T+6K[4"
MOR07*10QAL?Q.'8XSZ*:G_9)^.WQ,^,7BS7KK7='CD\)2DO#>(GDQV4@&!#&
M3S*#W!)(/)(S@^G:?^R7\(]+NOM$/@FQ>3.=MQ)+,G_?#N5_2O5;'3[72[.*
MTLK:&TM85VQP01A$1?0*. /I5UL1@8TI4\/2=WUET]/Z^\C#8/-9UX5<;B%R
MQ^S!:/UNO\_*Q8HHHKPSZD*^0/\ @H=\5#HOA#2_ UE-MN]8<7=Z%/(MT;Y%
M/LT@S_VR/K7U_7&^)O@YX(\9:T-7USPQIVJZF%51<W4(=\+]T<]A7?@:U/#U
MXU:JNE^?0\G-<-7QF$GAZ$E%RTN^W7[]CYO^$O[!?@W5/ASH-]XL&J#7[RV6
MYN8X+A8UCW_,J;2IP54J#SU!KK7_ ."?OPL9&"_VTK$8#?;%X]_N5]*T5M/-
M,9*3DJC5_,Y:>0Y;3A&#HQ=ENUJ_,_.C]E'Q+>_ ']I'5/ >MR>5:ZC.VE3%
MN%\]6/V>0>S$[1[2YK]%ZXO7?@SX&\3>(&UW5/"^FWNLLR,;Z6$>:2@ 4[O4
M   ^PKM*688J&,G&K%6E;7U[E9/E]7+:4\/.2E"[<>Z3Z/\ KJPHHHKRSWBO
MJ'_(/N?^N3?R-?E9^R_\;M*^ _Q%U/7M7L+S4+>XT^2S6.RV[PS2QOD[B!C"
M'\Q7ZLNHD5E895A@@]Q7FO\ PS1\*_\ H0]%_P# 85[67XRCAZ=2E7BVIVV\
MKGS&;Y;B<;6H5\+-1E3OOYV_R/$_^'D7@C_H6=>_\@__ !=>P_ 7]HC1OV@+
M769]'TV^TY=+:))/MVSY_,#XV[6/38>OJ*M_\,S_  K_ .A#T7_P&%=1X-^&
M_A?X=QW2>&M#L]$2Z*F<6<83S"N=N?IN/YFHQ%3 2IM4*<E+S9I@Z&;PK1EB
MJT90ZI+7;3IW.DHHHKR#Z,*^0OVEOVEOB5\&/BO8M:^'@G@R&/RU-P@:+4F8
M LWFKS&R] O48)(((%?7M5=2TNRUJQEL]0M(+ZTE&)+>YC62-QZ%2"#79A:U
M.A4YJL%-=CS<PPU;%4>2A5=.5[W7ET?E_6VA\OZ1_P %%/A[=::)=0TG7+"]
M ^:WCBBE7/HK[US^(%?.^E7FI_M8_M66>NZ3I#Z?8+=VUQ.WWO(M8-H+R,.-
MS!,#W( SUK[9O/V4?A+?71N)/ ^GJ^<[86DB3_OA6"_I7?>$_!.@> ]-^P>'
MM'L]&M"=S1V<*Q[SZL1RQ]SDU[$<=@\*I2PE-J;5M7HCYNIE.9X^4(9A6BZ<
M6G[JU=N^BM\C;HHHKYL^V"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_
!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>May 14, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May 14,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CENTESSA PHARMACEUTICALS PLC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">X0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40445<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3rd Floor<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">1 Ashley Road<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine3', window );">Entity Address, Address Line Three</a></td>
<td class="text">Altrincham<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Cheshire<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">WA14 2DT<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">GB<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CountryRegion', window );">Country Region</a></td>
<td class="text">+1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(617)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">468-5770<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001847903<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">98-1612294<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Ordinary shares, nominal value &#163;0.002 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CNTA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=cnta_AmericanDepositarySharesMember', window );">American Depositary Shares</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">American Depositary Shares, each representing one ordinary share, nominal value &#163;0.002 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CNTA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CountryRegion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Region code of country</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CountryRegion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 3 such as an Office Park</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=cnta_AmericanDepositarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=cnta_AmericanDepositarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( ! YKEI&QTU(E0   ,T    0    9&]C4')O<',O87!P+GAM
M;$W/30O", P&X+]2=K>9BAZD#D0]BIZ\SRYUA;8I;83Z[^T$/VYY><@;HBZ)
M(B:VF$7Q+N1M,S+'#4#6(_H^R\JABJ'D>ZXQW8&,L1H/I!\> \.B;=> A3$,
M.,SBM[#IU"Y&9W7/ED)WLCI1)L/B6#0ZL2<?J]P<"A#G>B4^BQ-+.9<K!?^+
M4\L54Y[FRF_\9 6_![H74$L#!!0    ( ! YKEIN:RC_[P   "L"   1
M9&]C4')O<',O8V]R92YX;6S-DE%+PS 0Q[^*Y+V]IG4BH<N+8T\*@@/%MY#<
MMF"3AN2DW;<WK5N'Z ?P,7?__.YW<*T.0O<1GV,?,)+%=#.ZSB>APYH=B8(
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M@2";_-;;I/;=X Q\U*M:I60K$3]+!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F
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M<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ $#FN6JK$(A8S 0  (@(
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M%S?W1:[-XPFNWPQP>'3^ 5!+ P04    "  0.:Y:99!YDAD!  #/ P  $P
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MPP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ $#FN6IE<G",0!@
MG"<  !,              ( !X0$  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"
M% ,4    "  0.:Y:WSFK<S$%  #!%P  &               @($B"   >&PO
M=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ $#FN6I^@&_"Q @
MX@P   T              ( !B0T  'AL+W-T>6QE<RYX;6Q02P$"% ,4
M"  0.:Y:EXJ[',     3 @  "P              @ %E$   7W)E;',O+G)E
M;'-02P$"% ,4    "  0.:Y:JL0B%C,!   B @  #P              @ %.
M$0  >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ $#FN6B0>FZ*M    ^ $
M !H              ( !KA(  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS
M4$L! A0#%     @ $#FN6F60>9(9 0  SP,  !,              ( !DQ,
J %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @  W10

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>26</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="cnta-20250514.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cnta.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="cnta-20250514.htm">cnta-20250514.htm</File>
    <File>cnta-20250514.xsd</File>
    <File>cnta-20250514_def.xml</File>
    <File>cnta-20250514_lab.xml</File>
    <File>cnta-20250514_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "cnta-20250514.htm": {
   "nsprefix": "cnta",
   "nsuri": "http://www.cnta.com/20250514",
   "dts": {
    "inline": {
     "local": [
      "cnta-20250514.htm"
     ]
    },
    "schema": {
     "local": [
      "cnta-20250514.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "cnta-20250514_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "cnta-20250514_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cnta-20250514_pre.xml"
     ]
    }
   },
   "keyStandard": 26,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 1,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 3,
   "entityCount": 1,
   "segmentCount": 2,
   "elementCount": 33,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 29
   },
   "report": {
    "R1": {
     "role": "http://www.cnta.com/role/Cover",
     "longName": "0000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "cnta-20250514.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "cnta-20250514.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "cnta_AmericanDepositarySharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cnta.com/20250514",
     "localname": "AmericanDepositarySharesMember",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "American Depositary Shares",
        "label": "American Depositary Shares [Member]",
        "documentation": "American Depositary Shares"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Domain]",
        "label": "Class of Stock [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockMember",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares",
        "label": "Common Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CountryRegion",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Country Region",
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Information [Line Items]",
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Information [Table]",
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line Two",
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line Three",
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Country",
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Ex Transition Period",
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Axis]",
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001847903-25-000069-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001847903-25-000069-xbrl.zip
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M1ZSZ;G/E6YC<*6;&6/G!_'IG[#P <_,8[AX+GHEQ<%W/ZV%B^"E%Q:T)?Z9
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MW(_VKN_;H]=6=PWQ0YPYLELR:3OL2D->XC=UD9^U2LTX$BSG_S9AF#:$09+
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MO"35.?0@";4]C2:93@*;$NDV\)?$1<7MGOGSAVM1SJ><BT1*9&>"4Y.Y8I@
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MY-;M<32I[22T*;/=AH?+?FB*3#^($TJ,PI2569H""@4!,D\XEBC)"?1<WN]
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MQ\+C#O.;^R[+//^T83YM9X/D\?XW6N:;X,/3!]<?E%_E?[(\??!_4$L#!!0
M   ( ! YKEH+DU5]Z!L  .\B 0 1    8VYT87!R+7$Q,C R-2YH=&WM7>MS
MVTB._WY_15^RF[&K*$6DWG8F51XGLY-*XLS&F<O>IZL6V9)ZS5?XL*/]ZP]
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MXDE*G/C K&$$S)#P*+B<;'EL2^';62" \IPB-P 0X$%H4'X YM_//?H-ORJ
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MKLF2O7J_*_+J>9/O7_7+.KN$V".:ZO_[G_:8@\%%BYJMQAQ=OC\_IJ4!K"W
MI8=LSQ<N/:7H \!3/-LA)@T)7_/UL!_70<(DTP@ 93@;(VR9TA42+K^I0@;Z
M'-.F=D(+S4].TG)\^!'4$]C)/H)XQR(,00(&>Q__6,7.IZ;O\G_^Q-FE&CEA
M#GXEF 539??TF1;0)S5A8'<ZK=/BXDG5=CBK>LBUZX-(&K>9 +.][B"2PM)\
M&8E7IZC O .'ZO#<(^<)]B\%'P:^ 4%V),8 'Q$-8!U_B0:W,)-I<$>ISP&-
MP-".RTQKLX^T<B](\X08Q((<H;EVD[@1AP(@(>[J1G]ARGW[83WDB4!OWZ@.
MCMQ<814!)D5<'L;B)/OE%, "1":3$^G3L.FFNQSJ!*:EWE#F)0%R$B=[L_ZZ
M3E^]3IS%[[J->K_;6?EUHV[>\;MFK[7IG<"/&,+47U\T\U.N,L[X 18>E.3*
MC9EJFO5NI[U;IFY.K%7O]C<FJ!*R>DVS(%IUB^[!.FDPDT# FJ=O<6GYV+!^
M2%;X$P>U>#;=0@$0F9J'MOZ]6[UPF^HQ<+NOSW#=.&;O<2T=#>YL-U5N?A]$
MC/O&GM8&["F?ZMXR@Q>7&FQ;B.'P=(WTL./R:62W 0A#X7V2-J8<B^D3<2W\
M5&P@L5L94%6#==OX-):B[=\1_R%$9RBK&=$W6!44X&_S@GZ@P1<'3:=XEFK4
M9MN %[QZ:78:IX_# /QJ2T8\Y%0[J/"^JS"5Y%BGU='A\IGZK1V\KB6HDH/_
MDJ_'%587>PL*<Y?A5]6]/])8R_*,\O'\@8"T<D;-DD^XK\42S\)J]G,&U/F5
MUG9"7XH_RN>*FTVCU6K>S1.7"#/NN90LR^BTK;))J7SS]8%0436L=;;+GBKZ
M+>ZQ=T!(MUB")6*OB"4P+:/9;&UI"=9H^6/9ZTVU:4^E!%ZUV2N;E,HW7Y]%
MFAK[YU69;U[W< #4FT&U>Z3ZRF<4CIH-H]OM'E<AX?6H 'S/I-HQ&OU&):1:
M/GOPK #[!US^QN,F9P]MP+:"P#N ]OV%@UVCU]]VQ>Z V9\ZQV*T^V;9A%2^
MV?JL$N*YQ=8+4 ?<OK<IUB/+Z-T!G%<4@E=30&VK7R(!E6^6/BLTK;8EAN'7
MIGV["DFS(VVNCW&KPKNM7AZ =15L@FDTK$[9,-L!6,\9;M-H-[?PK =0O;]Y
M\($8JOU$R4XG_*<XY,*?9=;4:AG=9J\26=-#+GSS7'C7:'?:E9!J^>S!LT+O
M'W(/<*_<R@&F5\$NF$:SWSW ]'(+J=4[9+\/0/WOZC1-M[@+QP&8/R,(9W4,
MLUD-"'< YIL#\Y[1:'4J(=7RV8/[ O-GVSRUY5AOU[9=M[(]"(7ED]-S0#5J
MN<B>V6OLB X!U]G(N_>6[AOF>=BQEN49Y>/Y@R9\^DOF'_TM?=Q _:367W(T
MV2XGY.]!)/#("W4 @SU19]RH'3L9=_"P\3OWGNZ;\]S/C$-GZ\;30U+HR</!
M+4+!0S[H?M60E3/A?_F1X+1A/!O1(0]@N*^Y=&GS3MS$/\:#Q#T>70F]H6>^
M*SA5YM#Y-X+.1Y5X5,6<Z5<G*/"?!U"VST5]W9Y9HJ*^0]7E_&YC[<.V T\$
MY*L=/Q^ ^F8H<+\2RY9A;E/&LQ4/*@3M]TJH9O..S6J'Y8*"-\@NR5C;(N4Z
MY,@>-2_Y2$L(#RB-PQ)"92'0MR#A[AP$NG.AQ)X@GT=TC*63_^:;]6XW^'*C
M@2.K9UC=YGYBO(/Z[KWZ-KM&W]RB].6 91\POTWS#>8'"6L^EWW L]N@Q28P
MT@E23*.7%=#>@\3R2>I!5^<;55O:R8J Z5PXD+#T>331!\35V(#'^JQM1^*Q
MD<X! M]CV;?Z2*%*>*!1M[;8K:U\%0<'=:N8NMTA/WZ F'<LH:B<G_U.?PB'
M<:"*C\2<KXU9D"9Q IX6MS=Y*,>[;T!ZNW:.52BU4BLT3:,!_[=;V_;L;<>.
M"M56[)> ^WVCU^L:7>O^![T]G7S+9R3(M[RFVK.WBX=29QQO-.L=/"\T#&*)
M)6@GD7#I'(65)\_KPZ4;TUOX( [0(*^\9?98ZD:]T2-55V)=<5Z]^G><+R6&
MX"!J@TCPJQH?)B(ZX>X-G\1S+X*WZ)'U6_6F!0-;1=,6IW(7SN9><449SZ#'
ME\<Q9W^"+_6X+5)2:0AJ7;O\Q <(66* !O ;I1\YXH3?N,M]6[#+L1!)7*)1
M+!HR',51ZO/4D4#Y]D?*/R&MS3[2RCTPI4G,I,^2<9#"LYQX>[+7SXT5=J R
M!]YWS'K?O-OYZVM/4>_6S>[=#F=?_TK3O-M!\FN)[=2;C=5?%Q_[\$>I+\$O
M3WFP]@;6"QG^#(X8WY 3[X0MO(&(EA\H_AQ:+U7=!(]C<%CW[K+<NPJ?9[7M
MTSF/U>F2-OXB?J3RFKLP9Q=J: Y9SBIE.<U&VS#;U=^)]:!U5=*Z9J]I6-8.
M=ZUZ9F<A9 ?64("TM*MOI6/?S^:HIMDWNJUM3V,\]+ ]=3*U9_2W=DX/**5G
MA?!4GY@"^W<R!YNZVO+IF=FPC'YKVW[)\J&@/1=3OV5T]@4U6.V2FX-B[/\X
MN\_M&P[?;O#EGFIMJVOTMK:(5=I2\J##>Z_#W8[1[6][F/>3Z/"#=)IN7X6[
M2<_$@U:K[Y#$YY.?=R4?2'=]&%^^CN7MGO$,([$U8CUD.ZODAYJ6T6P=4NP'
MI7O*L74Z1M/<X2Z-SRK#_BGP1RP1D<<<,5B]\>E^)FG-1M^PVM8AEUYV,?6,
M?NN.5<EE2Z97)'NV"3)_=GM4M4RCO754OA4G*I2%WR_1=MO@">X(.BJ0<"G;
M9E)EHO!9!>C*NE.?WSAP@4WQJY<]R^R>4F%<,GEFRZ?-7L>P6H=S DLNIE8#
M/.\N5[F?54RX@ "I>K9H,WY982TVM,RZ;60^&7Y8M[HO:\H]BQ]B9?9>_*G&
MNNUA=CS/V?$ :[X[F1U[T?#\>A X$_@Q3CSW[?\#4$L! A0#%     @ $#FN
M6E:KX8.!$   L7$  !$              ( !     &-N=&$M,C R-3 U,30N
M:'1M4$L! A0#%     @ $#FN6D1B/G@9 P  .@H  !$              ( !
ML!   &-N=&$M,C R-3 U,30N>'-D4$L! A0#%     @ $#FN6GQ9[XO+"
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E=&%P<BUQ,3(P,C4N:'1M4$L%!@     &  8 A@$  +]/      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>cnta-20250514_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cnta="http://www.cnta.com/20250514"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cnta-20250514.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001847903</identifier>
        </entity>
        <period>
            <startDate>2025-05-14</startDate>
            <endDate>2025-05-14</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001847903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-14</startDate>
            <endDate>2025-05-14</endDate>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001847903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cnta:AmericanDepositarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-14</startDate>
            <endDate>2025-05-14</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="c-1" id="f-28">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-29">0001847903</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2025-05-14</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">CENTESSA PHARMACEUTICALS PLC</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">X0</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-40445</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-6">98-1612294</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-7">3rd Floor</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="c-1" id="f-8">1 Ashley Road</dei:EntityAddressAddressLine2>
    <dei:EntityAddressAddressLine3 contextRef="c-1" id="f-9">Altrincham</dei:EntityAddressAddressLine3>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-10">Cheshire</dei:EntityAddressCityOrTown>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-11">WA14 2DT</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCountry contextRef="c-1" id="f-12">GB</dei:EntityAddressCountry>
    <dei:CountryRegion contextRef="c-1" id="f-13">+1</dei:CountryRegion>
    <dei:CityAreaCode contextRef="c-1" id="f-14">(617)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-15">468-5770</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-16">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-17">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-18">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-19">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-2" id="f-20">Ordinary shares, nominal value &#xa3;0.002 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-2" id="f-21">CNTA</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-2" id="f-22">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="c-3" id="f-23">American Depositary Shares, each representing one ordinary share, nominal value &#xa3;0.002 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-3" id="f-24">CNTA</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-3" id="f-25">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-26">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="c-1" id="f-27">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
